Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
13.02
-0.40 (-2.98%)
Feb 21, 2025, 4:00 PM EST - Market closed
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 296 employees as of December 31, 2023. The number of employees increased by 28 or 10.45% compared to the previous year.
Employees
296
Change (1Y)
28
Growth (1Y)
10.45%
Revenue / Employee
$468,608
Profits / Employee
-$660,591
Market Cap
1.52B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 296 | 28 | 10.45% |
| Dec 31, 2022 | 268 | 121 | 82.31% |
| Dec 31, 2021 | 147 | 93 | 172.22% |
| Dec 31, 2020 | 54 | 25 | 86.21% |
| Dec 31, 2019 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ARQT News
- 3 days ago - Arcutis to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 17 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Odell Beckham Jr. and Arcutis Tackle Seborrheic Dermatitis in a "Clear Win for Your Skin" - PRNewsWire
- 5 weeks ago - Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million - GlobeNewsWire
- 3 months ago - Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up? - Seeking Alpha
- 3 months ago - Arcutis Biotherapeutics, Inc. (ARQT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference - GlobeNewsWire